Gujarat cancels sale licences of 50 pharma firms in counterfeit-drug crackdown
Gujarat’s FDCA has cancelled the sale licences of 50 pharmaceutical firms, ordered two manufacturing units to close and suspended eight others. The regulator also inspected 2,238 food businesses and collected 2,591 food samples as festival-season monitoring intensified.
What happened
Gujarat FDCA cancelled licenses of 50 pharma firms, shut two manufacturing units and suspended eight others amid action against counterfeit medicines. It also inspected 2,238 food businesses and tested 2,591 samples, with intensified monitoring of festival-season staples.
Key facts
- 50 pharmaceutical firms had sale licenses cancelled
- 2 drug manufacturing units received closure orders
- 8 manufacturing-company licenses suspended
- 11 drug manufacturing licenses cancelled
- 588 antibiotic samples collected in rural-area quality drive
- 2,238 food business operators inspected in August 2026
- 2,591 food samples collected for laboratory testing
Why this matters
Acquirers and partners should intensify diligence on licence status, manufacturing practices and supplier quality controls for Gujarat-linked pharma and food retail targets.
What to watch
- Publication of the names, product categories and distribution footprints of the 50 firms with cancelled licences.
- Additional FDCA action against wholesalers, retail chemists, e-pharmacy fulfillment sites or food manufacturers.
- Reported counterfeit-drug seizures, recalls, adverse-event cases or expanded inter-state investigations.
- Festival-season food sample failure rates and follow-on closures, fines or public naming of outlets.
- Evidence of price increases or persistent shortages in affected generic medicines and high-turn food categories.
- Audit Gujarat suppliers, licences, batch records and product traceability, prioritizing high-risk generics, nutraceuticals, dairy, sweets and packaged festival foods.
- Quarantine inventory sourced from newly sanctioned firms and prepare substitution plans for affected SKUs.
- Increase incoming-quality testing, expiry controls, temperature logs and store-level documentation ahead of inspections.
- Diversify procurement through approved distributors while avoiding overconcentration in a small number of replacement vendors.
- Prepare customer and regulator communication protocols for recalls, stock withdrawals and counterfeit-product allegations.